Pain Quality Predicts Lidocaine Analgesia among Patients with Suspected Neuropathic Pain

被引:17
|
作者
Carroll, Ian R. [1 ]
Younger, Jared W. [1 ]
Mackey, Sean C. [1 ]
机构
[1] Stanford Univ, Sch Med, Palo Alto, CA 94040 USA
关键词
Lidocaine; Pain; Neuropathic Pain; Pain Quality; Sodium Channel Blockade; Intravenous Lidocaine; McGill Pain Questionnaire; Factor Analysis;
D O I
10.1111/j.1526-4637.2010.00807.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. Oral sodium channel blockers have shown mixed results in randomized controlled trials despite the known importance of sodium channels in generating pain. We hypothesized that differing baseline pain qualities (e.g. "stabbing" vs "dull") might define specific subgroups responsive to intravenous (IV) lidocaine-a potent sodium channel blocker. Design. A prospective cohort study of 71 patient with chronic pain suspected of being neuropathic were recruited between January 2003 and July 2007 and underwent lidocaine infusions at Stanford University Hospital in a single-blind nonrandomized fashion. Baseline sensory pain qualities were measured with the Short-Form McGill Pain Questionnaire (SF-MPQ). Pain intensity was measured with a visual analog scale (VAS). Results. Factor analysis demonstrated two underlying pain quality factors among SF-MPQ sensory items: a heavy pain and a stabbing pain. Baseline heavy pain quality, but not stabbing quality predicted subsequent relief of pain intensity in response to lidocaine. In contrast, these factors did not predict divergent analgesic responses to placebo infusions. In response to each 1 mcg/mL increase in lidocaine plasma level, patients with high heavy pain quality drop their VAS 0.24 (95% CI 0.05-0.43) more points than those with low heavy pain quality (P < 0.013). Conclusions. "Heavy" pain quality may indentify patients with enhanced lidocaine responsiveness. Pain quality may identify subgroups among patients with suspected neuropathic pain responsive to IV lidocaine. Further investigation is warranted to validate and extend these findings.
引用
收藏
页码:617 / 621
页数:5
相关论文
共 50 条
  • [11] Levodopa analgesia in experimental neuropathic pain
    Cobacho, Nuria
    De la Calle, Jose L.
    Gonzalez-Escalada, Jose R.
    Paino, Carlos L.
    BRAIN RESEARCH BULLETIN, 2010, 83 (06) : 304 - 309
  • [12] TOPICAL LIDOCAINE RELIEVES PERIPHERAL NEUROPATHIC PAIN
    GALER, BS
    NEUROLOGY, 1995, 45 (04) : A366 - A366
  • [13] Lidocaine 5% Patch in Localized Neuropathic Pain
    Nair, Abhijit S.
    Mantha, Srinivasa Shyam Prasad
    Azharuddin, Mohammad
    Rayani, Basanth Kumar
    INDIAN JOURNAL OF PALLIATIVE CARE, 2019, 25 (04) : 594 - +
  • [14] Comparison of pain quality descriptors in cancer patients with nociceptive and neuropathic pain
    Mystakidou, Kyriaki
    Parpa, Efi
    Tsilika, Eleni
    Pathiaki, Maria
    Galanos, Antonis
    Vlahos, Lambros
    IN VIVO, 2007, 21 (01): : 93 - 97
  • [15] New analgesics for neuropathic pain: The lidocaine patch
    Argoff, CE
    CLINICAL JOURNAL OF PAIN, 2000, 16 (02): : S62 - S66
  • [16] SUBCUTANEOUS LIDOCAINE FOR TREATMENT OF NEUROPATHIC CANCER PAIN
    BROSE, WG
    COUSINS, MJ
    PAIN, 1991, 45 (02) : 145 - 148
  • [17] QUALITY OF LIFE IN PATIENTS WITH PERIPHERAL NEUROPATHIC PAIN
    Tamburin, S.
    Magrinelli, F.
    Maier, A.
    Praitano, M.
    Cazzarolli, C.
    Dongili, A.
    Lauriola, M.
    Fiaschi, A.
    Zanette, G.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2012, 17 : S53 - S53
  • [18] Pain affects the quality of life of neuropathic patients
    D. Cocito
    I. Paolasso
    C. Pazzaglia
    A. Tavella
    F. Poglio
    P. Ciaramitaro
    A. Scarmozzino
    F. M. Cossa
    B. Bergamasco
    L. Padua
    Neurological Sciences, 2006, 27 : 155 - 160
  • [19] Pain affects the quality of life of neuropathic patients
    Cocito, D.
    Paolasso, I.
    Pazzaglia, C.
    Tavella, A.
    Poglio, F.
    Ciaramitaro, P.
    Scarmozzino, A.
    Cossa, E. M.
    Bergamasco, B.
    Padua, L.
    NEUROLOGICAL SCIENCES, 2006, 27 (03) : 155 - 160
  • [20] Intravenous lidocaine infusions in a multidirectional model of treatment of neuropathic pain patients
    Anna Przeklasa-Muszyńska
    Magdalena Kocot-Kępska
    Jan Dobrogowski
    Maciej Wiatr
    Joanna Mika
    Pharmacological Reports, 2016, 68 : 1069 - 1075